SET Domain, Bifurcated 2 (SETDB2) Peptide
SETDB2
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN983609
Quick Overview for SET Domain, Bifurcated 2 (SETDB2) Peptide (ABIN983609)
Target
SETDB2
(SET Domain, Bifurcated 2 (SETDB2))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-SETDB2 antibody (Catalog #: ARP48955_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- SETDB2 (SET Domain, Bifurcated 2 (SETDB2))
-
Background
-
Proteins that contain a SET domain, such as SETDB2, modulate gene expression epigenetically through histone H3 methylation. SETDB2 is likely a histone H3 methyltransferase, as it contains both the active site and flanking cysteine residues required for catalytic activity.
Alias Symbols: CLLD8, CLLL8, KMT1F, C13orf4
Protein Size: 707 -
Molecular Weight
- 77 kDa
-
Gene ID
- 83852
-
NCBI Accession
- NM_001160308
Target
-
You are here:
